| Product Information |
BR-1418_PI_01.pdf
|
| Registration Number |
BR-1418
|
| Generic Name |
Ofatumumab
|
| Brand Name |
Bonspri
|
| Dosage Strength |
20 mg/ 0.4 mL
|
| Dosage Form |
Solution for Injection (SC)
|
| Classification |
Prescription Drug (RX)
|
| Pharmacologic Category |
-
|
| Packaging |
1 mL (Net content: 0.4 mL) Type I pre-filled glass syringe with bromobutyl rubber stopper, staked needle (29 GX 12") with rigid needle shield, polypropylene plunger rod, and needle safety device in a blister tray closed with lidding paper (Box of 1's)
|
| Manufacturer |
Novartis Pharma Stein AG (Technical Operations Schweiz, Stein Steriles)
|
| Country of Origin |
Switzerland
|
| Trader |
Novartis Pharma AG
|
| Importer |
Novartis Healthcare Philippines, Inc.
|
| Distributor |
Novartis Healthcare Philippines, Inc.
|
| Application Type |
Monitored Release (MR)
|
| Issuance Date |
12 September 2022
|
| Expiry Date |
12 September 2027
|